ELV
$428.09 · +0.7% today · +5.9% 5d · +15.3% 3m · +24.2% 1y
Daily score85
Weekly score53
Long-term score95
Close
Scores (0–100)
Components — latest (2026-10-14)
Close
428.09
1D return
+0.7%
5D return
+5.9%
Rel volume
1.76
CMF 20
-0.04
OBV slope 20
-0.06
Up-vol ratio 10
0.84
Short ratio
0.61
Short ratio Δ
+4.4%
Persistence 10
1.00
Inflow mean 5d
-0.04
Inflow mean 60d
0.10
Momentum 12-1
+21.2%
% of 52w high
+100.0%
vs 200d
+17.0%
Volatility 60d
+25.2%
Dollar vol 20d
$508.67M
Insider buys 90d
$1.37M
Insider buyers 90d
2.00
Revenue growth
+1.4%
Fundamentals — Elevance Health · Health Care
as of 2026-10-22- P/E
- 17.1
- P/B
- 2.15
- ROE
- 12.6%
- Operating margin
- 3.6%
- Debt / equity
- 0.68
- FCF yield
- 3.3%
- Years profitable
- 5/5
- BM score
- 25
- Moat flag
- No
Insider trades (Form 4)
| Filed | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-10-23 | Kaye Mark | EVP & CFO | Sell | 827 | $446.05 | $368.9K |
| 2026-10-23 | Kaye Mark | EVP & CFO | Sell | 273 | $447.19 | $122.1K |
| 2026-10-23 | Kaye Mark | EVP & CFO | Sell | 400 | $434.00 | $173.6K |
| 2026-10-23 | Kaye Mark | EVP & CFO | Sell | 321 | $435.25 | $139.7K |
| 2026-10-23 | Kaye Mark | EVP & CFO | Sell | 1.7K | $436.20 | $724.1K |
| 2026-10-23 | Kaye Mark | EVP & CFO | Sell | 560 | $437.07 | $244.8K |
| 2026-10-23 | Kaye Mark | EVP & CFO | Sell | 240 | $438.22 | $105.2K |
| 2026-10-23 | Kaye Mark | EVP & CFO | Sell | 1.2K | $439.25 | $509.5K |
| 2026-10-23 | Kaye Mark | EVP & CFO | Sell | 1.7K | $440.44 | $757.6K |
| 2026-10-23 | Kaye Mark | EVP & CFO | Sell | 2.3K | $441.34 | $1.03M |
| 2026-10-23 | Kaye Mark | EVP & CFO | Sell | 480 | $442.61 | $212.5K |
| 2026-10-23 | Kaye Mark | EVP & CFO | Sell | 440 | $443.81 | $195.3K |
| 2026-10-23 | Kaye Mark | EVP & CFO | Sell | 160 | $444.85 | $71.2K |
| 2026-07-17 | BOUDREAUX GAIL | President and CEO | Buy | 680 | $366.41 | $249.2K |
| 2026-07-17 | BOUDREAUX GAIL | President and CEO | Buy | 2.0K | $368.25 | $753.1K |
| 2026-07-17 | PERU RAMIRO G | Director | Buy | 1.0K | $366.05 | $366.1K |
| 2026-06-15 | Penczek Ronald W | CAO & Controller | Sell | 369 | $403.16 | $148.8K |
| 2026-06-12 | Dixon Robert L JR | Director | Sell | 151 | $401.77 | $60.7K |
| 2026-05-20 | Penczek Ronald W | CAO & Controller | Sell | 1.5K | $403.13 | $617.2K |
Congress trades
No congressional trades on file for ELV.